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The article presents a review of new techniques being used for the preparation of lipo-
somes. A total of 28 publications were examined. In addition to the theories, characteristics
and problems associated with traditional methods, the advantages and drawbacks of the
latest techniques were reviewed. In the light of developments in many relevant areas, a
variety of new techniques are being used for liposome preparation and each of these new
technique has particular advantages over conventional preparation methods. However,
there are still some problems associated with these new techniques that could hinder their
applications and further improvements are needed. Generally speaking, due to the intro-
duction of these latest techniques, liposome preparation is now an improved procedure.
These applications promote not only advances in liposome research but also the methods
for their production on an industrial scale.
© 2014 Shenyang Pharmaceutical University. Production and hosting by Elsevier B.V. All
rights reserved.1. Introduction
Liposomes are enclosed vesicles formed by lipid materials,
such as phospholipids, dispersed in an aqueous medium. One
or more bilayers are formed, which have a similar structure to316.
eng).
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University. Production anthe cell membrane, separating the inner water phase from the
outer [1].
Because of their special structure, liposomes have some
excellent advantages when used in drug delivery systems.
First of all, the enclosed vesicles can separate the inner phase
from the outside one and, thus, improve the stability of thesity
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poorly water-soluble drug exhibits enhanced bioavailability.
In addition, a sustained or controlled drug release profile can
be achieved after encapsulation. Also, liposomes possess a
good cell affinity with excellent biodegradability. Further-
more, the target effect of liposomal preparations can change
the in vivo distribution of the loaded drug, improving the
therapeutic index of certain drugs [2e5]. Also, many ligands
can be modified on the surface of the liposomes and these
modifications can alter the characteristics and biological
behavior of the final product.
Liposomes, with their special characteristics such as
modifiable morphology, particle size, Zeta potential, encap-
sulation efficiency, and drug release profile can enhance the
properties of certain drugs. For instance, liposomes with a
particle size under 120 nm can produce better tumor accu-
mulation [6]. Moreover, the encapsulation efficiency and sta-
bility of liposomes should be as high as possible to produce
high drug concentrations as well as preventing drug leakage.
Today, a great variety of liposome preparation methods are
available and each of them has particular features and special
advantages. If suitable methods are selected and corre-
sponding new techniques are used, new liposomal formula-
tions can be prepared easily and efficiently. With the recent
advances, more and more novel technologies have been
applied to the manufacture the wonderful vesicles in recent
years. However, liposome researchers sometimes have a
problem when faced with the huge variety of new technolo-
gies. In the light of this, we have produced a systematic review
of the new technologies to help in the selection of suitable
preparation methods to meet different needs.2. Conventional methods of liposome
preparation
Since the pioneering discovery of Bangham, a variety of
methods have been reported in the literatures for liposome
preparation including thin-film hydration or the Bangham
method [7], reversed phase evaporation [8], solvent-injection
techniques [9], and detergent dialysis [10]. These are the
most commonly used ones. Some techniques have been
employed to help reduce the size of vesicles, for instance,
sonication [11], high pressure extrusion [12] and microﬂ-
uidization [13].
Unfortunately, those conventional preparation methods
have a number of problems which can be classified into the
following four categories: (1) The particle size of liposomes is
too large or has a broad distribution so there is a need for post-
processing granulation. (2) The organic solvent remaining in
the final product is also a serious issue since it not only affects
the stability of some protein or polypeptide drugs, but also
adversely affects clinical treatment. (3) Since many lipids are
sensitive to temperature, the sterilization of liposomal prep-
arations can be a problem. So there is a preference for prep-
aration processes which can be carried out in an ultraclean
environment. However, conventional methods do not always
fulfill this requirement. (4) In some procedures careful moni-
toring is needed and this subjective techniquemight influence
reproducibility.To solve these problems, many novel preparation tech-
nologies have been applied for the preparation of liposomes.3. Novel technologies for liposome
preparation
Nowadays, supercritical fluid technology, dual asymmetric
centrifugation, membrane contactor technology, cross-flow
filtration technology and freeze drying technology have been
employed for liposome preparation.3.1. Liposome preparation methods based on
supercritical fluid technology
Supercritical fluids are non-condensable fluids, which are
very dense at certain temperatures and pressures beyond the
critical values. As the line between the liquid and gas phase
disappears, supercritical fluids have many particular char-
acteristics compared with conventional fluids. Among these
characteristics, solvents with special properties have attrac-
ted a great deal of interest from researchers. Remarkably,
supercritical carbon dioxide (scCO2) is an excellent organic
solvent substitute. In spite of its low cost, it is non-toxic and
is not inflammable. In addition, it has a relatively low critical
temperature and pressure (31 C and 73.8 bar) with the
dissolution properties analogous to those of nonpolar sol-
vents [14].
3.1.1. Supercritical anti-solvent (SAS) method
Regarding classical thin-film dispersion methods, lipids are
always dispersed on the inner surface of the glass flask to
form a lipophilic thin film. Similarly, the supercritical anti-
solvent (SAS) method is being used to achieve a fine and ho-
mogenous dispersion of lipid materials. Briefly, in the SAS
method, lipids dissolve readily in scCO2 and then precipitate
in the form of ultrafine particles. The experimental procedure
for SAS is shown in Fig. 1A.
Phospholipid and cholesterol is dissolved in an organic
solution and placed in a glass container which, together with
a source of CO2 gas, is connected to pumps linked to a pre-
cipitation vessel. Gaseous CO2 is pumped into a high-
pressure precipitation vessel by spraying through capillary
tubes and then transformed into a supercritical phase
because of the sudden change in temperature and pressure.
Subsequently, the lipids are extracted into the supercritical
phase as soon as the evaporation of the organic solvent is
completely introduced, which lead to supersaturation of the
solute in the scCO2 phase and then the lipid materials pre-
cipitate. Afterwards, the organic solvent is removed by CO2
continuously pumped into the vessel to produce fine lipid
particles. Finally, liposomes are obtained by directly adding
aqueous phase [15].
Data obtained show that SAS liposomes have no significant
differences compared with conventional Bangham liposomes
in terms of the particle size, encapsulation efficiency and
stability [15]. Nonetheless, organic solvent can be removed
completely using SAS, which is of great value.
Fig. 1 e Experimental set-up for supercritical fluid technology-based liposome preparation methods: (A) the Supercritical
anti-solvent (SAS) method and (B) the Supercritical reverse phase evaporation (SPER) method.
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In the conventional reverse phase evaporation method,
organic solvents are usually used to dissolve lipid materials.
Because of the dissolution properties of scCO2, the supercrit-
ical fluidmight be an excellent substitute for organic solvents.
In 2001, Otake and his colleagues [16] first reported that
liposomes can be prepared by a supercritical reverse phase
evaporation method using scCO2 as the solvent for lipids. The
apparatus used is shown in the Fig. 1B.
Briefly, the apparatus consists of three parts: a viewing cell
with a variable volume, an HPLC pump for feeding aqueous
solution into the viewing cell and a high-pressure pump for
CO2 and pressure control by moving the piston in the viewing
cell. The ethanol solution of lipid materials is measured with
an electronic balance and fed into the cell. After the lipid
materials are placed in the viewing cell the cell is sealed, and a
magnetic tip is used for stirring inside the viewing cell and
gaseous CO2 is introduced into the cell. The temperature is
then raised to a chosen value, which could reach both the
phase transition temperature of the phospholipids and the
supercritical temperature of carbon dioxide. The pressure is
also kept above the supercritical value. After several seconds
to reach equilibration, an aqueous solution of the model drug
is slowly introduced into the cell through the HPLC pump,
until a sufficient amount of solution is reached. Finally, the
pressure is reduced to release CO2 and a homogeneous lipo-
somal dispersion is formed.
Large unilamellar liposomes with ellipsoidal apsides of
0.1e1.2 mm have been reported. There is also an increasing
tendency for the shape of the liposomes to become spherical
with decreasing liposome size [16]. It has been shown that the
SRPE method allows efficient preparation of large unilamellar
liposomes with a membrane structure that is quite similar to
that of biological cells such as erythrocytes. The SRPE method
has a particular advantage in that only a small amount of an
organic solvent, like ethanol, can be used.
In 2006, Otake et al. developed the SRPE method in which
they put an aqueous phase together with the solid lipid ma-
terials into a sealed viewing cell. The temperature and pres-
sure were adjusted to suitable values and then the CO2 was
introduced. After equilibration, CO2 escapes and liposomes
are formed [17]. The liposomes prepared by the improved
supercritical reverse phase evaporation (ISRPE) method have
an enhanced entrapment compared with those obtained bySRPE. Also, the process is shorter because of a reduction in the
apparatus required. In addition, the ISRPE method does not
require any organic solvents and thus completely avoids any
problems caused by organic residues which is very significant.
However, whether the former or the latter procedure is used,
liposomes prepared by SRPE do not have a narrow particle size
distribution. So post-procedures are needed to optimize this
excellent method.
3.2. Dual asymmetric centrifugation (DAC)
Dual asymmetric centrifugation (DAC) is a special kind of
centrifugation. Vials in DAC turn around the main rotation
axis at a defined distance and speed, which is similar to that
used in conventional centrifugation. However, the main dif-
ference between DAC and normal centrifugation is that the
vials in the DAC process also turn around their own center
(vertical axis) while they still turn around the center of the
centrifuge as in the normal centrifugation process. In other
words, the vial make two movements in the DAC process.
Interestingly, this results in two overlaying movements of the
sample material in the centrifugation vial. The main rotation
pushes the sample material in an outward direction in
response to centrifugal forces, while the rotation of the
centrifugation vial around its own center pushes the sample
material in the opposite direction due to adhesion between
the sample material and the rotating vial. If there is sufficient
adhesion of the sample material to the vial material and the
sample material is viscous enough, the latter movement, the
inward transport of the sample material, is effective. Both of
these factors may significantly affect the transference of en-
ergy into the sample material [18]. Therefore, DAC is particu-
larly appropriate for the homogenization of viscousmaterials.
Vesicular phospholipid gel (VPG) is a highly concentrated
lipid dispersion system, which can be diluted by a suitable
aqueous phase and form liposomes [19]. Since lipids are
usually viscous materials, and VPG is sufficiently viscous.
Hence, DAC can be used for the preparation of VPG and lipo-
somes (Fig. 2).
Hirsch et al. [18] have carried out the homogenization in a
dual asymmetric centrifuge in multiples of 5-min runs (since
5 min is the maximum runtime of the DAC that can be
selected, the instrument is immediately restarted after every
5-min run until the total mixing time is reached) directly after
Fig. 2 e Schematic representation of the principle of dual
asymmetric centrifuging.
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chloride solution. After the DAC process is finished, the VPGs
are redispersed in a double volume of 0.9% NaCl solution to
produce a liposomal dispersion. In this way, conventional and
stealth liposomal preparations can be made and their mean
particle sizes were 70e100 nm and 100e120 nm, respectively.
A model drug, calcein, and siRNA had encapsulation effi-
ciencies of 60e80% and 43e71%, respectively [20].
Compared with conventional methods of liposome prepa-
ration, the DACmethod has several significant advantages: (1)
The DAC equipment is small in size, easy to operate and offers
good reproducibility. (2) Using the DAC method, liposomes
with a small particle size can be produced directly without
requiring other processes for granulation or homogenization.
(3) Water-soluble drugs have a high entrapment efficiency. (4)
No organic solvents are used in DAC for the dispersing lipid,
which is of particular significance for liposomal injections.
However, there are some drawbacks associated with DAC. For
instance, the formulations usually need to contain a high
amount of phospholipids to obtain a sufficient viscosity. In
order to take full advantages of DAC and its further applica-
tions, there is a need to overcome the aforementioned flaws
by formulation optimization and method improvement or
integration.3.3. Liposome preparation methods based on membrane
contactor technology
Membrane contactors can be used to mix two materials
efficiently, and many kinds of dispersion systems can beFig. 3 e Schematic representation of liposome pprepared using a membrane contactor. It has been reported
that membrane contactors have already been applied to the
preparation of emulsions, precipitates, polymeric and lipidic
nanoparticles and, most recently, for the preparation of li-
posomes. Since homogenization of lipid and water phases is
a key procedure in liposome preparation, this apparatus can
be applied for preparing liposome. Based on the theoretical
advantage of the ethanol injection method for liposomes,
Laouini and co-workers [21] combined a membrane con-
tactor with a hollow fiber module. This combination could
increase the membrane area and thus offers improved
efficiency.
As can be seen in Fig. 3, the aqueous phase is poured into
themodule by the action of a pump,while the organic phase is
placed in the pressurized vessel. The nitrogen in the bottle can
push the oil phase into the system. Then, the connecting valve
to the nitrogen bottle is opened and the gas pressure is set at a
fixed level. The aqueous phase is subsequently pumped
through the membrane contactor module. When water rea-
ches the inlet of the hollow fibermodule, the valve connecting
the pressurized vessel to the filtrate side of the membrane
device is opened so that the organic phase can permeate
through the pores of the hollow fibers. When the aqueous and
lipid phases meet, liposomes are formed spontaneously. The
experiment is stopped when air bubbles start to appear in the
tube joining the pressurized vessel to the membrane module,
indicating that the pressurized vessel is empty. Then, the
liposomal suspension is stabilized under magnetic stirring.
Finally, the ethanol is removed by rotary evaporation to
complete the final preparation.
Basing on the forementioned system, in 2010, Jaafar-Maalej
et al. [22] were the first to use an SPG (Shirasu porous glass)
membrane and obtained a final product with a mean particle
size of approximately 100 nm and 98% encapsulation effi-
ciency for the model drug beclomethasone dipropionate.
Later, in 2011, Laouini et al. [21] produced a similar
productd100 nm and 93% (model drug: spironolactone). By
adjusting the flow rate of the pump and the pressure of the
nitrogen gas bottle, the process conditions can be easily
controlled, which makes the preparation procedure easy to
reproduce and increase to an industrial scale. Shortly after
this, in the same year, Thi Thuy Pham et al. [23] reported their
work on industrial scale liposome preparation using a mem-
brane contactor. Their product could be obtained in a very
reproducible manner.reparation based on a membrane contactor.
Fig. 4 e Schematic representation of the experimental
setup of a cross-flow filtration unit.
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based techniques have the following characteristics: (a) ho-
mogeneous and small particle size, (b) multilamellar vesicles,
(c) high encapsulation efficiency for lipophilic drugs and (d)
simplicity for scaling up. However, if certain active drug-
loading methods can be introduced successfully, drugs with
a high water solubility can also undergo enhanced entrap-
ment. This would make the technology even more attractive.
3.4. Cross-flow filtration detergent depletion method
Detergent-mediated liposome production is based on the
solubilization of lipids with the aid of a suitable detergent
resulting in the formation of mixed micelles. Then, the
detergent is removed, which leads to the breaking up of mi-
celles and repacking into lipid bilayers. The edge tensionTable 1 e Features of new techniques in liposome preparation
New technique Particle Size (nm) Encapsulation efficienc
Supercritical fluid
technology
100e10,000 [15,16] 10e20% [15]
20% (fluorescein isocyana
dextran) [16]
Dual asymmetric
centrifugation
70e120 [20] 80% (calcein)
71% (siRNA) [20]
Membrane contactor
technology
~100 [21,22] 93% (spironolactone) [21]
98% (beclomethasone) [22
Cross-flow filtration
detergent depletion
method
~50 [25] Data not shown
Freeze drying double
emulsions method
<200 [26] 87% (calcein)
93% (flurbiprofen)
19% (5-fluorouracil) [26]increases and finally the curved bilayers shrink and form
unilamellar vesicles [24]. However, the membranes still
contain a great amount of detergent. The membrane-bound
detergents may produce severe effects in the bilayer. Hence,
fast removal ofmembrane-bound detergent is a crucial step in
detergent removal techniques.
Therefore, a technique, which combines the advantages of
known detergent removal methods with an accelerated and
efficient removal of detergent, can markedly reduce the
preparation time and heterogeneous liposome lamelarity. In
addition, the procedure would be economical and preferable
even if carried out continuously and under sterile conditions.
In 1998, Regine Peschka et al. [25] developed a combined
conventional detergent depletion method with a cross-flow
technique, a combination which can meet the demand for
the fast removal of detergents. A schematic representation of
the experimental setup of the cross-flow filtration unit is
shown in Fig. 4.
The cross-flow filtration unit consists of a starting reser-
voir, a pump, a filtration device (membrane system) and
tubing with an integrated rotary slide valve and a manometer
to monitor the retentate pressure. By increasing the retentate
pressure, the pressure on the membrane increases, leading to
the fast removal of detergent. The starting reservoir contains
the mixed micelle solution which is subjected to tangential
filtration. The filtration unit is equipped with a single mem-
brane or membrane cassettes with a cutoff of a selected mo-
lecular weight.
By using the cross-ﬂow filtration process, liposomes of
defined size, homogeneity and high stability can be obtained.
Large quantities of liposomes can be produced in a signi-
ficantly shorter time compared with other methods used for.
y Features (advantages and drawbacks)
te
a. Organic solvent can be excluded completely, or even need
not to be used.
b. Postal procedures should be utilized to achieve a narrow
particle size distribution.
c. Efficiency of encapsulation has no significant improvement
compared with Bangham method.
d. The recovery of raw material is usually raw.
a. The equipment of DAC is small in size and easy in operation
with a good reproducibility.
b. Liposomes with small particle size can be achieved.
c. Water soluble drugs could have an efficient entrapment.
d. High phospholipids content should be in the formulation to
obtain a sufficient viscosity.
]
a. Homogeneous and small multilamellar liposomes with high
encapsulation efficiency for lipophilic drugs can be obtained.
b. It is easy to scale-up.
c. The encapsulation for hydrophilic drugs still need further
investigation.
a. Liposomes of defined size, homogeneity and high stability
can be prepared in a short time.
b. Sterile products can be obtained by the presented methods.
c. The waste filtrate can be recycled to minimize costs of
production.
a. Sterile preparation with good storage stability can be
achieved.
b. Cryoprotectants are always carbohydrates, which limits the
applications for patients with diabetes.
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tained by these methods when starting with sterile filtered
mixedmicelles and autoclaved devices. In addition, the waste
filtrate can be recycled to minimize the production costs.
3.5. Freeze drying double emulsion method
Based on the traditional double emulsions method, in the
freeze drying double emulsion method, different kinds of
cryoprotectants are added to the inner or outer water phase of
the liposome formulation. After the formation of a W/O/W
type multiple emulsion, a sterilization process is carried out.
Subsequently, liposomes in the form of lyophilized powder
can be obtained via a freeze drying procedure. Before use, the
powder should be hydrated to the original volume of thewater
phase to be transformed into a liposome suspension.
Using this procedure, the liposomes usually have a small
size below 200 nm. If appropriate cryoprotectants are chosen,
we can obtain a liposome preparation with a small mean
particle size (approximately 100 nm), and a highly efficient
encapsulation (87% for calcein, 93% for flurbiprofen and 19%
for 5-fluorouracil), good reproducibility and high stability. In
addition, a sterile product can be also achieved with a good
storage stability by the application of freeze drying as in other
drug delivery systems [26e28].
However, this method also has its drawbacks. The used
organic solvents might pose critical problems such as safety
issues associated with the disposal of residual solvents and
damage to the freeze dryer. In addition, cryoprotectants are
always carbohydrates which t limits their use for patients
with diabetes.4. Future
Combinedwith the basic preparation principles of liposomes, a
greatmanyuniquenewtechnologieshavebeenused toprepare
liposomes.They canbeused to solve certain problemsposed by
newpreparation procedures. In summary, everynewly-applied
techniquehas itsownprosandconsandtheir featuresare listed
in Table 1. Although deficiencies or limitations still exist in
various technologies, the desired effects can be obtained by
drawingonthestrengthsof individualmethods.Weexpect that
researchers will be helped tomake a choice with the aid of this
review to fulfill their particular requirements.
The unique applications of new technologies will also help
in the pursuit of industrial-scale pharmacy applica-
tionsdsimplified operation, high repeatability, suitability for
industrial-scale up. The introduction of new technologies will
produce more liposome formulations from the laboratory,
which will be suitable for industrial-scale production and
even more effective clinical applications.r e f e r e n c e s
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